World Urbanization Prospects: The 2018 Revision. https://www.un.org/development/desa/pd/content/world-urbanization-prospects-2018-revision. Accessed 22 Nov 2022.
Urban Development. https://www.worldbank.org/en/topic/urbandevelopment/overview. Accessed 22 Nov 2022.
Giles-Corti B, Vernez-Moudon A, Reis R, Turrell G, Dannenberg AL, Badland H, et al. City planning and population health: a global challenge. Lancet. 2016;388:2912–24.
Alirol E, Getaz L, Stoll B, Chappuis F, Loutan L. Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis. 2011;11:131–41.
Article PubMed PubMed Central Google Scholar
Wolf J, Pruss-Ustun A, Cumming O, Bartram J, Bonjour S, Cairncross S, et al. Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health. 2014;19:928–42.
Pruss-Ustun A, Bartram J, Clasen T, Colford JJ, Cumming O, Curtis V, et al. Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries. Trop Med Int Health. 2014;19:894–905.
Article PubMed PubMed Central Google Scholar
Barrett B, Charles JW, Temte JL. Climate change, human health, and epidemiological transition. Prev Med. 2015;70:69–75.
Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, et al. Managing the health effects of climate change: Lancet and University College London Institute for Global Health Commission. Lancet. 2009;373:1693–733.
Li X, Song J, Lin T, Dixon J, Zhang G, Ye H. Urbanization and health in China, thinking at the national, local and individual levels. Environ Health. 2016;15(Suppl 1):32.
Article PubMed PubMed Central Google Scholar
Tong MX, Hansen A, Hanson-Easey S, Cameron S, Xiang J, Liu Q, et al. Infectious diseases, urbanization and climate change: challenges in future China. Int J Environ Res Public Health. 2015;12:11025–36.
Article CAS PubMed PubMed Central Google Scholar
Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schunemann HJ. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395:1973–87.
Article CAS PubMed PubMed Central Google Scholar
Seo JY, Seo JH, Kim MH, Ki M, Park HS, Choi BY. Pattern of hepatitis A incidence according to area characteristics using national health insurance data. J Prev Med Public Health. 2012;45:164–73.
Article PubMed PubMed Central Google Scholar
Lobel HO, Mccollum RW. Some observations on the ecology of infectious hepatitis. Bull World Health Organ. 1965;32:675–82.
CAS PubMed PubMed Central Google Scholar
Linder K, Malani P. Hepatitis A. JAMA. 2017;318:2393.
Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int. 2021;15:1068–82.
Sa-Nguanmoo P, Posuwan N, Vichaiwattana P, Vuthitanachot V, Saelao S, Foonoi M, et al. Declining trend of hepatitis A seroepidemiology in association with improved public health and economic status of Thailand. PLoS ONE. 2016;11: e151304.
Koroglu M, Jacobsen K, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017;10:513–7.
Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34:600–9.
Article CAS PubMed Google Scholar
Pereira TM, Mantovani SAS, Branco FLCC, Braña AM, Oliart-Guzmán H, Delfino BM, et al. Hepatitis A seroprevalence in preschool children in Assis Brazil, Acre, Brazil, in 2003 and 2010. Int Health. 2016;8:132–41.
Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015;87:569–74.
Zhu Y, Yuan Z, Zhao Q, Chen G, Xu B. Seroprevalence of hepatitis A virus antibody in a population aged 0–30 years in Shanghai, China: implications for hepatitis A immunization. Epidemiol Infect. 2013;141:556–62.
Article CAS PubMed Google Scholar
Ceran N, YükselKocdogan F, Mert D, Erdem İ, Dede B, Adaleti R, et al. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat. 2012;19:72–6.
Article CAS PubMed Google Scholar
Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–7.
Liu M, Liu X, Huang Y, Ma Z, Bi J. Epidemic transition of environmental health risk during China’s urbanization. Sci Bull (Beijing). 2017;62:92–8.
Hepatitis A. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a. Accessed 22 Nov 2022.
Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, Wang L, et al. Urbanisation and health in China. Lancet. 2012;379:843–52.
Article PubMed PubMed Central Google Scholar
Li X, Wang C, Zhang G, Xiao L, Dixon J. Urbanisation and human health in China: spatial features and a systemic perspective. Environ Sci Pollut Res Int. 2012;19:1375–84.
Article PubMed PubMed Central Google Scholar
Cui F, Hadler SC, Zheng H, Wang F, Wu Z, Hu Y, et al. Hepatitis A surveillance and vaccine use in China from 1990 through 2007. J Epidemiol. 2009;19:189–95.
Article PubMed PubMed Central Google Scholar
Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381:1987–2015.
Article PubMed PubMed Central Google Scholar
Ren X, Wu P, Wang L, Geng M, Zeng L, Zhang J, et al. Changing epidemiology of hepatitis A and hepatitis E viruses in China, 1990–2014. Emerg Infect Dis. 2017;23:276–9.
Article PubMed PubMed Central Google Scholar
Gullon P, Varela C, Martinez EV, Gomez-Barroso D. Association between meteorological factors and hepatitis A in Spain 2010–2014. Environ Int. 2017;102:230–5.
Sarin SK, Kumar M, Eslam M, George J, Al MM, Akbar S, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5:167–228.
Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, et al. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. BMJ. 2020;369: m1043.
Article PubMed PubMed Central Google Scholar
Geng MJ, Zhang HY, Yu LJ, Lv CL, Wang T, Che TL, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021;12:6923.
Article CAS PubMed PubMed Central Google Scholar
Sun X, Wang F, Zheng H, Miao N, Wang H, Yin Z, et al. Epidemiological characteristics of hepatitis A and hepatitis E in different periods of vaccination in China, 2004–2015. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:1351–5.
National Population and Health Science Data Sharing Platform. https://www.phsciencedata.cn/. Accessed 08 Jan 2022.
Diagnostic criteria of viral hepatitis A. http://www.nhc.gov.cn/wjw/s9491/200907/41984.shtml. Accessed 10 Mar 2023.
Sun X, Wang F, Zheng H, Miao N, Yuan Q, Cui F, et al. The impact of expanded program on immunization with live attenuated and inactivated hepatitis A vaccines in China, 2004–2016. Vaccine. 2018;36:1279–84.
Zhang M, Wu R, Xu H, Uhanova J, Gish R, Wen X, et al. Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study. BMJ Open. 2019;9: e028248.
Article PubMed PubMed Central Google Scholar
China Statistical Yearbook. http://www.stats.gov.cn/tjsj/ndsj/. Accessed 08 Jan 2022.
China Meteorological Data Sharing Service System. http://data.cma.cn/. Accessed 08 Jan 2022.
Guo C, Du Y, Shen SQ, Lao XQ, Qian J, Ou CQ. Spatiotemporal analysis of tuberculosis incidence and its associated factors in mainland China. Epidemiol Infect. 2017;145:2510–9.
Article CAS PubMed PubMed Central Google Scholar
Mao Y, Zhang N, Zhu B, Liu J, He R. A descriptive analysis of the spatio-temporal distribution of intestinal infectious diseases in China. BMC Infect Dis. 2019;19:766.
留言 (0)